<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:hpo ids='HP_0001915'>Aplastic anemia</z:hpo> is a rare but severe complication of thionamide therapy </plain></SENT>
<SENT sid="1" pm="."><plain>Although colony-stimulating factors have been used extensively in thionamide-induced <z:mp ids='MP_0000334'>agranulocytosis</z:mp> with good results, the same might not apply to <z:hpo ids='HP_0001915'>aplastic anemia</z:hpo> </plain></SENT>
<SENT sid="2" pm="."><plain>We present a case of a patient with <z:chebi fb="0" ids="50673">methimazole</z:chebi>-induced <z:hpo ids='HP_0001915'>aplastic anemia</z:hpo> in which, as administration of recombinant human granulocyte-monocyte colony-stimulating factor for a week did not result in an increase in peripheral blood cell count, standard immunosuppressive treatment was needed to restore <z:mpath ids='MPATH_458'>normal</z:mpath> hematopoiesis </plain></SENT>
<SENT sid="3" pm="."><plain>The clinical characteristics of this patient are compared with those of previous cases of thionamide-induced <z:hpo ids='HP_0001915'>aplastic anemia</z:hpo>, especially with the only other reported patient in which colony-stimulating factors were used </plain></SENT>
</text></document>